

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.82432083 |
| 2 | ensheathment of neurons (GO:0007272) | 6.55664366 |
| 3 | axon ensheathment (GO:0008366) | 6.55664366 |
| 4 | myelination (GO:0042552) | 6.54559895 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.38882333 |
| 6 | response to methylmercury (GO:0051597) | 6.17412372 |
| 7 | myelin maintenance (GO:0043217) | 5.85413048 |
| 8 | cholesterol biosynthetic process (GO:0006695) | 5.57995435 |
| 9 | amyloid precursor protein metabolic process (GO:0042982) | 5.53456775 |
| 10 | negative regulation of protein localization to cell surface (GO:2000009) | 5.16698663 |
| 11 | establishment of mitochondrion localization (GO:0051654) | 5.11624926 |
| 12 | sterol biosynthetic process (GO:0016126) | 5.01274260 |
| 13 | negative regulation of neurotransmitter transport (GO:0051589) | 4.79735705 |
| 14 | regulation of collateral sprouting (GO:0048670) | 4.74562421 |
| 15 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.64601521 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.63462159 |
| 17 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.62153360 |
| 18 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.51389036 |
| 19 | creatine metabolic process (GO:0006600) | 4.32304282 |
| 20 | isoprenoid biosynthetic process (GO:0008299) | 4.31045486 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 4.19831112 |
| 22 | response to lipoprotein particle (GO:0055094) | 4.16656655 |
| 23 | L-amino acid import (GO:0043092) | 4.10793850 |
| 24 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.06621090 |
| 25 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.04812460 |
| 26 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.02228029 |
| 27 | photoreceptor cell differentiation (GO:0046530) | 4.00106235 |
| 28 | eye photoreceptor cell differentiation (GO:0001754) | 4.00106235 |
| 29 | glutamate secretion (GO:0014047) | 3.94941517 |
| 30 | glycerophospholipid catabolic process (GO:0046475) | 3.88314112 |
| 31 | sodium ion export (GO:0071436) | 3.88022945 |
| 32 | import into cell (GO:0098657) | 3.81643598 |
| 33 | very long-chain fatty acid metabolic process (GO:0000038) | 3.76618247 |
| 34 | neurotransmitter uptake (GO:0001504) | 3.72166872 |
| 35 | neuronal ion channel clustering (GO:0045161) | 3.65511321 |
| 36 | amyloid precursor protein catabolic process (GO:0042987) | 3.61987782 |
| 37 | response to redox state (GO:0051775) | 3.61759246 |
| 38 | oligodendrocyte differentiation (GO:0048709) | 3.61292653 |
| 39 | synaptic vesicle maturation (GO:0016188) | 3.51588178 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.50687157 |
| 41 | astrocyte development (GO:0014002) | 3.49918052 |
| 42 | apical protein localization (GO:0045176) | 3.47327961 |
| 43 | neuron remodeling (GO:0016322) | 3.45869028 |
| 44 | membrane tubulation (GO:0097320) | 3.41871658 |
| 45 | magnesium ion transport (GO:0015693) | 3.40508474 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.37886553 |
| 47 | synaptic vesicle exocytosis (GO:0016079) | 3.37098992 |
| 48 | protein neddylation (GO:0045116) | 3.35159148 |
| 49 | substantia nigra development (GO:0021762) | 3.32532162 |
| 50 | protein palmitoylation (GO:0018345) | 3.32515764 |
| 51 | asymmetric protein localization (GO:0008105) | 3.29547749 |
| 52 | extracellular matrix assembly (GO:0085029) | 3.28524187 |
| 53 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.24390816 |
| 54 | presynaptic membrane organization (GO:0097090) | 3.21522924 |
| 55 | GPI anchor biosynthetic process (GO:0006506) | 3.20107294 |
| 56 | thioester biosynthetic process (GO:0035384) | 3.16758049 |
| 57 | acyl-CoA biosynthetic process (GO:0071616) | 3.16758049 |
| 58 | heme transport (GO:0015886) | 3.12753008 |
| 59 | cell-cell junction maintenance (GO:0045217) | 3.12576851 |
| 60 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.12237302 |
| 61 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.12237302 |
| 62 | GPI anchor metabolic process (GO:0006505) | 3.11581378 |
| 63 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.11481074 |
| 64 | myelination in peripheral nervous system (GO:0022011) | 3.11456105 |
| 65 | peripheral nervous system axon ensheathment (GO:0032292) | 3.11456105 |
| 66 | iron coordination entity transport (GO:1901678) | 3.08158761 |
| 67 | astrocyte differentiation (GO:0048708) | 3.06627426 |
| 68 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.05886671 |
| 69 | amino acid import (GO:0043090) | 3.04527821 |
| 70 | cell volume homeostasis (GO:0006884) | 3.04470781 |
| 71 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.01899500 |
| 72 | cAMP biosynthetic process (GO:0006171) | 2.97218443 |
| 73 | potassium ion homeostasis (GO:0055075) | 2.96999228 |
| 74 | positive regulation of glial cell differentiation (GO:0045687) | 2.96244044 |
| 75 | activation of protein kinase A activity (GO:0034199) | 2.95186351 |
| 76 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.94438214 |
| 77 | peripheral nervous system development (GO:0007422) | 2.92247554 |
| 78 | limb bud formation (GO:0060174) | 2.89257746 |
| 79 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.89073267 |
| 80 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.86976261 |
| 81 | adult walking behavior (GO:0007628) | 2.85404676 |
| 82 | basement membrane organization (GO:0071711) | 2.85357387 |
| 83 | cGMP-mediated signaling (GO:0019934) | 2.85310376 |
| 84 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.85189425 |
| 85 | purine nucleotide transport (GO:0015865) | 2.83599661 |
| 86 | regulation of cell communication by electrical coupling (GO:0010649) | 2.82221367 |
| 87 | cell communication by electrical coupling (GO:0010644) | 2.80098453 |
| 88 | postsynaptic membrane organization (GO:0001941) | 2.79083837 |
| 89 | cartilage condensation (GO:0001502) | 2.79018125 |
| 90 | cell aggregation (GO:0098743) | 2.79018125 |
| 91 | chondroitin sulfate catabolic process (GO:0030207) | 2.78911287 |
| 92 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.77991664 |
| 93 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.77626305 |
| 94 | barbed-end actin filament capping (GO:0051016) | 2.77243447 |
| 95 | potassium ion import (GO:0010107) | 2.77118751 |
| 96 | negative regulation of macroautophagy (GO:0016242) | 2.77033372 |
| 97 | glycosylceramide metabolic process (GO:0006677) | 2.74705293 |
| 98 | regulation of somitogenesis (GO:0014807) | 2.73565221 |
| 99 | positive regulation of astrocyte differentiation (GO:0048711) | 2.72720426 |
| 100 | positive regulation of gliogenesis (GO:0014015) | 2.68110570 |
| 101 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.66561118 |
| 102 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.66032630 |
| 103 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.65527252 |
| 104 | negative regulation of axonogenesis (GO:0050771) | 2.64518845 |
| 105 | detection of calcium ion (GO:0005513) | 2.64439686 |
| 106 | organ growth (GO:0035265) | 2.64057475 |
| 107 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.63880491 |
| 108 | response to dietary excess (GO:0002021) | 2.63330931 |
| 109 | positive regulation of synapse maturation (GO:0090129) | 2.63325484 |
| 110 | vitamin A metabolic process (GO:0006776) | 2.62958877 |
| 111 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.62909096 |
| 112 | peptidyl-cysteine modification (GO:0018198) | 2.62573736 |
| 113 | cell junction maintenance (GO:0034331) | 2.62405830 |
| 114 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.62022545 |
| 115 | melanocyte differentiation (GO:0030318) | 2.61441153 |
| 116 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.59909736 |
| 117 | pigment cell differentiation (GO:0050931) | 2.58638320 |
| 118 | enteric nervous system development (GO:0048484) | 2.58521387 |
| 119 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.57472314 |
| 120 | regulation of synaptic vesicle transport (GO:1902803) | 2.57076438 |
| 121 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.56433794 |
| 122 | positive regulation of actin filament depolymerization (GO:0030836) | 2.55363347 |
| 123 | nucleotide transmembrane transport (GO:1901679) | 2.55306743 |
| 124 | positive regulation of pseudopodium assembly (GO:0031274) | 2.55042424 |
| 125 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.55015803 |
| 126 | locomotory exploration behavior (GO:0035641) | 2.54844941 |
| 127 | vocalization behavior (GO:0071625) | 2.54749188 |
| 128 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.54209578 |
| 129 | long-term synaptic potentiation (GO:0060291) | 2.54193124 |
| 130 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.53241704 |
| 131 | nerve growth factor signaling pathway (GO:0038180) | 2.52979588 |
| 132 | alcohol biosynthetic process (GO:0046165) | 2.52621988 |
| 133 | hyperosmotic salinity response (GO:0042538) | 2.51955659 |
| 134 | neurotransmitter secretion (GO:0007269) | 2.50654397 |
| 135 | regulation of synapse maturation (GO:0090128) | 2.47544991 |
| 136 | cerebellar granule cell differentiation (GO:0021707) | 2.47267820 |
| 137 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.47163106 |
| 138 | detection of temperature stimulus (GO:0016048) | 2.47115546 |
| 139 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.46101832 |
| 140 | cellular sodium ion homeostasis (GO:0006883) | 2.46053923 |
| 141 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.44894383 |
| 142 | cellular response to electrical stimulus (GO:0071257) | 2.43947226 |
| 143 | cholesterol metabolic process (GO:0008203) | 2.43851853 |
| 144 | neuronal action potential propagation (GO:0019227) | 2.43748967 |
| 145 | presynaptic membrane assembly (GO:0097105) | 2.43706059 |
| 146 | cell communication involved in cardiac conduction (GO:0086065) | 2.42884256 |
| 147 | negative regulation of JUN kinase activity (GO:0043508) | 2.42361716 |
| 148 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.42283195 |
| 149 | neuromuscular process controlling balance (GO:0050885) | 2.41832308 |
| 150 | L-glutamate transport (GO:0015813) | 2.40625045 |
| 151 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.40246951 |
| 152 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.40170181 |
| 153 | cranial nerve development (GO:0021545) | 2.39749475 |
| 154 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.39650058 |
| 155 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.39650058 |
| 156 | regulation of actin filament-based movement (GO:1903115) | 2.39242267 |
| 157 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.38419938 |
| 158 | dermatan sulfate metabolic process (GO:0030205) | 2.38214325 |
| 159 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.37310294 |
| 160 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.37310294 |
| 161 | cellular response to epinephrine stimulus (GO:0071872) | 2.37214828 |
| 162 | dermatan sulfate biosynthetic process (GO:0030208) | 2.36581687 |
| 163 | righting reflex (GO:0060013) | 2.34052386 |
| 164 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.33522029 |
| 165 | negative regulation of catenin import into nucleus (GO:0035414) | 2.30767574 |
| 166 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.30727941 |
| 167 | semaphorin-plexin signaling pathway (GO:0071526) | 2.29714463 |
| 168 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.29392917 |
| 169 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.28980103 |
| 170 | cardiac muscle contraction (GO:0060048) | 2.28783661 |
| 171 | cellular response to monoamine stimulus (GO:0071868) | 2.26535474 |
| 172 | cellular response to catecholamine stimulus (GO:0071870) | 2.26535474 |
| 173 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.26103506 |
| 174 | regulation of gonadotropin secretion (GO:0032276) | 2.25660552 |
| 175 | regulation of synaptic plasticity (GO:0048167) | 2.24749053 |
| 176 | glycosphingolipid biosynthetic process (GO:0006688) | 2.21945446 |
| 177 | striated muscle hypertrophy (GO:0014897) | 2.21846229 |
| 178 | growth hormone receptor signaling pathway (GO:0060396) | 2.21084552 |
| 179 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.20740800 |
| 180 | axon ensheathment in central nervous system (GO:0032291) | 13.1132689 |
| 181 | central nervous system myelination (GO:0022010) | 13.1132689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.02325720 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.01486890 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.83782879 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.75140923 |
| 5 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.66464993 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.38007523 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32601312 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.23755034 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.22532906 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.15738029 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.11499072 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.10467996 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09724651 |
| 14 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.07090002 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04339603 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.99929613 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.97101387 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96719731 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96719731 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.93225280 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93092497 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.90340103 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.89701318 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.88955704 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88307148 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85837366 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.84689755 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84077140 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82322247 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.81320671 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80644478 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.74266784 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73888076 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.72701234 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72695733 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71428349 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70276763 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59259656 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.57912987 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56629846 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56520408 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54876684 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54825885 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.54719570 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.51274670 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51234042 |
| 47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.50910941 |
| 48 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.50910941 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47172997 |
| 50 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.46877311 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46166160 |
| 52 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.44293421 |
| 53 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42628865 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41307976 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41220445 |
| 56 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.40974772 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39858370 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38799673 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38522500 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36837311 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36602104 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36602104 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31833920 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31319687 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29692448 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.29237550 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.28876320 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28628695 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27760066 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26614835 |
| 71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21886464 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21553789 |
| 73 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20922239 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20724707 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20032510 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19820813 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18357952 |
| 78 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.18214937 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16397292 |
| 80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.16275131 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16003334 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15123282 |
| 83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15067805 |
| 84 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14648758 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14479239 |
| 86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13223319 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13103079 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12664469 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12602991 |
| 90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11787531 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11148430 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11085870 |
| 93 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10529572 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09474649 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08687333 |
| 96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08524866 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07073833 |
| 98 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06933112 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06284143 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05549918 |
| 101 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05101834 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05074125 |
| 103 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.04947409 |
| 104 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04753296 |
| 105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04393598 |
| 106 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03590236 |
| 107 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03590236 |
| 108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03060035 |
| 109 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02681466 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02226573 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01080229 |
| 112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00859868 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00810115 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99827030 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99555853 |
| 116 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99446374 |
| 117 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98989781 |
| 118 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.98985969 |
| 119 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98405879 |
| 120 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.98373487 |
| 121 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98337649 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98316979 |
| 123 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98263350 |
| 124 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97803041 |
| 125 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97613565 |
| 126 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97165106 |
| 127 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.96860129 |
| 128 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.96504549 |
| 129 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.96450516 |
| 130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96137780 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96136997 |
| 132 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.95647082 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94781526 |
| 134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94592073 |
| 135 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93731824 |
| 136 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92844056 |
| 137 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.92727162 |
| 138 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.92458687 |
| 139 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92324815 |
| 140 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91764772 |
| 141 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90886865 |
| 142 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90745909 |
| 143 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.89858933 |
| 144 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89629679 |
| 145 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89450382 |
| 146 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.88540307 |
| 147 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88227728 |
| 148 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88140554 |
| 149 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88036724 |
| 150 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87960464 |
| 151 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87689541 |
| 152 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.87601442 |
| 153 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.87500158 |
| 154 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87346592 |
| 155 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87317192 |
| 156 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87083545 |
| 157 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.86065014 |
| 158 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84532436 |
| 159 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83189595 |
| 160 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79131058 |
| 161 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78249545 |
| 162 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.78095795 |
| 163 | AR_19668381_ChIP-Seq_PC3_Human | 0.77132201 |
| 164 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76918305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.60604548 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.10928190 |
| 3 | MP0003011_delayed_dark_adaptation | 3.88082504 |
| 4 | MP0003880_abnormal_central_pattern | 3.12804802 |
| 5 | MP0003690_abnormal_glial_cell | 3.09974234 |
| 6 | MP0004270_analgesia | 2.90612719 |
| 7 | MP0003329_amyloid_beta_deposits | 2.85337513 |
| 8 | MP0001529_abnormal_vocalization | 2.80650696 |
| 9 | MP0005171_absent_coat_pigmentation | 2.78050224 |
| 10 | MP0005503_abnormal_tendon_morphology | 2.76265633 |
| 11 | MP0005670_abnormal_white_adipose | 2.74467581 |
| 12 | MP0000751_myopathy | 2.64213667 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.47079619 |
| 14 | MP0003136_yellow_coat_color | 2.45847422 |
| 15 | MP0004885_abnormal_endolymph | 2.45629867 |
| 16 | MP0002272_abnormal_nervous_system | 2.39563648 |
| 17 | MP0004742_abnormal_vestibular_system | 2.38850815 |
| 18 | MP0001905_abnormal_dopamine_level | 2.38189971 |
| 19 | MP0005275_abnormal_skin_tensile | 2.36829498 |
| 20 | MP0001486_abnormal_startle_reflex | 2.35150956 |
| 21 | MP0003634_abnormal_glial_cell | 2.24444871 |
| 22 | MP0004142_abnormal_muscle_tone | 2.20782085 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.18375729 |
| 24 | MP0005409_darkened_coat_color | 2.17479695 |
| 25 | MP0003195_calcinosis | 2.16043727 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 2.11341363 |
| 27 | MP0004043_abnormal_pH_regulation | 2.04000207 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 2.02817838 |
| 29 | MP0005410_abnormal_fertilization | 1.99517096 |
| 30 | MP0002064_seizures | 1.91498221 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.88520283 |
| 32 | MP0000778_abnormal_nervous_system | 1.84867920 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.84626172 |
| 34 | MP0004272_abnormal_basement_membrane | 1.82285050 |
| 35 | MP0003632_abnormal_nervous_system | 1.79924826 |
| 36 | MP0004858_abnormal_nervous_system | 1.79830498 |
| 37 | MP0002229_neurodegeneration | 1.72494468 |
| 38 | MP0008260_abnormal_autophagy | 1.64842117 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.63221001 |
| 40 | MP0000604_amyloidosis | 1.62626401 |
| 41 | MP0004130_abnormal_muscle_cell | 1.60530365 |
| 42 | MP0003279_aneurysm | 1.56728193 |
| 43 | MP0000462_abnormal_digestive_system | 1.56716787 |
| 44 | MP0004134_abnormal_chest_morphology | 1.52941434 |
| 45 | MP0004381_abnormal_hair_follicle | 1.49556679 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.48739471 |
| 47 | * MP0003631_nervous_system_phenotype | 1.46999839 |
| 48 | MP0000383_abnormal_hair_follicle | 1.45056488 |
| 49 | MP0002108_abnormal_muscle_morphology | 1.44803261 |
| 50 | MP0003635_abnormal_synaptic_transmissio | 1.43880027 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.38908257 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.38206799 |
| 53 | MP0003879_abnormal_hair_cell | 1.37746861 |
| 54 | MP0001970_abnormal_pain_threshold | 1.35879177 |
| 55 | * MP0003633_abnormal_nervous_system | 1.33236301 |
| 56 | MP0009745_abnormal_behavioral_response | 1.32409904 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.31368544 |
| 58 | MP0006138_congestive_heart_failure | 1.31044062 |
| 59 | MP0005451_abnormal_body_composition | 1.30275384 |
| 60 | MP0004859_abnormal_synaptic_plasticity | 1.29195222 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.28232380 |
| 62 | MP0009046_muscle_twitch | 1.26112318 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.25897733 |
| 64 | MP0008569_lethality_at_weaning | 1.25642821 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.25283563 |
| 66 | MP0000955_abnormal_spinal_cord | 1.24249271 |
| 67 | MP0001958_emphysema | 1.21770566 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 1.20065775 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 1.19748751 |
| 70 | MP0000747_muscle_weakness | 1.17869960 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 1.17818619 |
| 72 | MP0005623_abnormal_meninges_morphology | 1.17633637 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.16781497 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.16463968 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.14739563 |
| 76 | MP0001440_abnormal_grooming_behavior | 1.14300404 |
| 77 | MP0000762_abnormal_tongue_morphology | 1.14111322 |
| 78 | MP0001963_abnormal_hearing_physiology | 1.12074080 |
| 79 | MP0000647_abnormal_sebaceous_gland | 1.10934949 |
| 80 | MP0003045_fibrosis | 1.08414046 |
| 81 | * MP0002066_abnormal_motor_capabilities/c | 1.08292791 |
| 82 | MP0005248_abnormal_Harderian_gland | 1.07519592 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 1.07411251 |
| 84 | MP0003878_abnormal_ear_physiology | 1.07411251 |
| 85 | MP0005195_abnormal_posterior_eye | 1.06407443 |
| 86 | MP0005375_adipose_tissue_phenotype | 1.05352506 |
| 87 | MP0001968_abnormal_touch/_nociception | 1.05009773 |
| 88 | MP0002938_white_spotting | 1.04869041 |
| 89 | MP0002067_abnormal_sensory_capabilities | 1.04427592 |
| 90 | MP0004215_abnormal_myocardial_fiber | 1.01530949 |
| 91 | MP0001851_eye_inflammation | 1.00557118 |
| 92 | MP0004036_abnormal_muscle_relaxation | 1.00532251 |
| 93 | MP0009840_abnormal_foam_cell | 0.99966800 |
| 94 | MP0002752_abnormal_somatic_nervous | 0.99487030 |
| 95 | * MP0002063_abnormal_learning/memory/cond | 0.99443608 |
| 96 | MP0000579_abnormal_nail_morphology | 0.98847991 |
| 97 | MP0005620_abnormal_muscle_contractility | 0.98522181 |
| 98 | MP0004087_abnormal_muscle_fiber | 0.97140239 |
| 99 | MP0002972_abnormal_cardiac_muscle | 0.96941289 |
| 100 | MP0005508_abnormal_skeleton_morphology | 0.96232587 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.96172027 |
| 102 | MP0002909_abnormal_adrenal_gland | 0.95190039 |
| 103 | MP0004145_abnormal_muscle_electrophysio | 0.94191695 |
| 104 | MP0002733_abnormal_thermal_nociception | 0.93793615 |
| 105 | MP0000003_abnormal_adipose_tissue | 0.90250310 |
| 106 | MP0002736_abnormal_nociception_after | 0.89894397 |
| 107 | MP0001177_atelectasis | 0.89789817 |
| 108 | MP0005386_behavior/neurological_phenoty | 0.88760732 |
| 109 | MP0004924_abnormal_behavior | 0.88760732 |
| 110 | MP0001299_abnormal_eye_distance/ | 0.88263368 |
| 111 | MP0005330_cardiomyopathy | 0.86036605 |
| 112 | MP0003091_abnormal_cell_migration | 0.85523277 |
| 113 | MP0003075_altered_response_to | 0.84874660 |
| 114 | MP0001346_abnormal_lacrimal_gland | 0.84185500 |
| 115 | MP0002971_abnormal_brown_adipose | 0.83789241 |
| 116 | MP0005595_abnormal_vascular_smooth | 0.82528885 |
| 117 | MP0004484_altered_response_of | 0.82363683 |
| 118 | MP0000749_muscle_degeneration | 0.81734806 |
| 119 | MP0006082_CNS_inflammation | 0.80065527 |
| 120 | MP0002060_abnormal_skin_morphology | 0.78588042 |
| 121 | MP0003938_abnormal_ear_development | 0.78460749 |
| 122 | MP0005253_abnormal_eye_physiology | 0.78359358 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.78190352 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.77049789 |
| 125 | MP0000015_abnormal_ear_pigmentation | 0.75815460 |
| 126 | MP0005369_muscle_phenotype | 0.75294862 |
| 127 | MP0009250_abnormal_appendicular_skeleto | 0.75201001 |
| 128 | MP0005388_respiratory_system_phenotype | 0.74677631 |
| 129 | MP0002133_abnormal_respiratory_system | 0.74677631 |
| 130 | MP0002822_catalepsy | 0.73644830 |
| 131 | MP0001348_abnormal_lacrimal_gland | 0.73341933 |
| 132 | MP0005165_increased_susceptibility_to | 0.73178096 |
| 133 | MP0004085_abnormal_heartbeat | 0.73076107 |
| 134 | MP0001340_abnormal_eyelid_morphology | 0.72873118 |
| 135 | MP0000569_abnormal_digit_pigmentation | 0.72335060 |
| 136 | MP0006072_abnormal_retinal_apoptosis | 0.71700705 |
| 137 | MP0002557_abnormal_social/conspecific_i | 0.68585316 |
| 138 | MP0003183_abnormal_peptide_metabolism | 0.68333007 |
| 139 | MP0002152_abnormal_brain_morphology | 0.68030729 |
| 140 | MP0004147_increased_porphyrin_level | 0.67250813 |
| 141 | MP0005535_abnormal_body_temperature | 0.67101541 |
| 142 | MP0005646_abnormal_pituitary_gland | 0.66718191 |
| 143 | MP0003937_abnormal_limbs/digits/tail_de | 0.66439446 |
| 144 | MP0000026_abnormal_inner_ear | 0.64403504 |
| 145 | MP0005408_hypopigmentation | 0.63605010 |
| 146 | MP0002933_joint_inflammation | 0.61518902 |
| 147 | MP0001501_abnormal_sleep_pattern | 0.60044884 |
| 148 | MP0001661_extended_life_span | 0.59716142 |
| 149 | MP0000566_synostosis | 0.59174382 |
| 150 | MP0002090_abnormal_vision | 0.59105211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.94306978 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.61908217 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.61908217 |
| 4 | Cerebral inclusion bodies (HP:0100314) | 5.08441103 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.86070406 |
| 6 | Peripheral hypomyelination (HP:0007182) | 4.50017249 |
| 7 | Parakeratosis (HP:0001036) | 4.44639507 |
| 8 | Onion bulb formation (HP:0003383) | 4.18493622 |
| 9 | Termporal pattern (HP:0011008) | 4.18167423 |
| 10 | Insidious onset (HP:0003587) | 4.18167423 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.99115214 |
| 12 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.91229912 |
| 13 | Obstructive sleep apnea (HP:0002870) | 3.87466467 |
| 14 | Increased serum pyruvate (HP:0003542) | 3.82656599 |
| 15 | Abnormality of glycolysis (HP:0004366) | 3.82656599 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 3.69272254 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.56728039 |
| 18 | Cerebral hypomyelination (HP:0006808) | 3.47554343 |
| 19 | Blue irides (HP:0000635) | 3.44737336 |
| 20 | Retinal dysplasia (HP:0007973) | 3.33699255 |
| 21 | Abnormal auditory evoked potentials (HP:0006958) | 3.30791467 |
| 22 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.26423782 |
| 23 | Upper limb amyotrophy (HP:0009129) | 3.24693157 |
| 24 | Distal upper limb amyotrophy (HP:0007149) | 3.24693157 |
| 25 | Hand muscle atrophy (HP:0009130) | 3.21936647 |
| 26 | Cerebral aneurysm (HP:0004944) | 3.21556222 |
| 27 | Spastic gait (HP:0002064) | 3.20951735 |
| 28 | Leukodystrophy (HP:0002415) | 3.18042329 |
| 29 | Scanning speech (HP:0002168) | 3.14614810 |
| 30 | Sensory axonal neuropathy (HP:0003390) | 3.13630072 |
| 31 | Heterochromia iridis (HP:0001100) | 3.09322727 |
| 32 | Type 1 muscle fiber predominance (HP:0003803) | 3.09207307 |
| 33 | Ankle clonus (HP:0011448) | 3.00419342 |
| 34 | Axonal loss (HP:0003447) | 2.92838165 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.90273689 |
| 36 | Dysmetria (HP:0001310) | 2.89955124 |
| 37 | Shallow orbits (HP:0000586) | 2.87430874 |
| 38 | Slow saccadic eye movements (HP:0000514) | 2.85507770 |
| 39 | Hypoplastic pelvis (HP:0008839) | 2.81467590 |
| 40 | Intention tremor (HP:0002080) | 2.81405440 |
| 41 | Upper limb muscle weakness (HP:0003484) | 2.80743527 |
| 42 | Hypoplasia of the iris (HP:0007676) | 2.76786464 |
| 43 | Hypophosphatemic rickets (HP:0004912) | 2.74982169 |
| 44 | Protrusio acetabuli (HP:0003179) | 2.73484266 |
| 45 | Stridor (HP:0010307) | 2.68922318 |
| 46 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.67225798 |
| 47 | Bundle branch block (HP:0011710) | 2.65616614 |
| 48 | Increased connective tissue (HP:0009025) | 2.60561215 |
| 49 | Cerebral hemorrhage (HP:0001342) | 2.59620556 |
| 50 | Alacrima (HP:0000522) | 2.58457210 |
| 51 | Myokymia (HP:0002411) | 2.56468746 |
| 52 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.54394087 |
| 53 | CNS hypomyelination (HP:0003429) | 2.53609484 |
| 54 | Autoamputation (HP:0001218) | 2.51263993 |
| 55 | Anteriorly placed anus (HP:0001545) | 2.49610923 |
| 56 | Foot dorsiflexor weakness (HP:0009027) | 2.47106723 |
| 57 | Torticollis (HP:0000473) | 2.46962075 |
| 58 | Absent septum pellucidum (HP:0001331) | 2.44641364 |
| 59 | Ocular albinism (HP:0001107) | 2.44188601 |
| 60 | Clumsiness (HP:0002312) | 2.42488165 |
| 61 | Abnormal pupillary function (HP:0007686) | 2.41582888 |
| 62 | Metabolic alkalosis (HP:0200114) | 2.41505430 |
| 63 | Spinal rigidity (HP:0003306) | 2.39547835 |
| 64 | Morphological abnormality of the inner ear (HP:0011390) | 2.37501239 |
| 65 | Spastic paraparesis (HP:0002313) | 2.34654540 |
| 66 | Methylmalonic acidemia (HP:0002912) | 2.33607640 |
| 67 | Pheochromocytoma (HP:0002666) | 2.33280004 |
| 68 | J-shaped sella turcica (HP:0002680) | 2.31254133 |
| 69 | Abnormality of binocular vision (HP:0011514) | 2.30119022 |
| 70 | Diplopia (HP:0000651) | 2.30119022 |
| 71 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.29788503 |
| 72 | Muscle fiber splitting (HP:0003555) | 2.29520513 |
| 73 | Increased circulating renin level (HP:0000848) | 2.29242239 |
| 74 | Abnormality of the foot musculature (HP:0001436) | 2.26836034 |
| 75 | Hypoventilation (HP:0002791) | 2.26563571 |
| 76 | Steppage gait (HP:0003376) | 2.23702840 |
| 77 | Spastic tetraparesis (HP:0001285) | 2.23546278 |
| 78 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22368873 |
| 79 | Postural tremor (HP:0002174) | 2.21756237 |
| 80 | Hepatosplenomegaly (HP:0001433) | 2.21557478 |
| 81 | Focal motor seizures (HP:0011153) | 2.17575284 |
| 82 | Iris hypopigmentation (HP:0007730) | 2.17327793 |
| 83 | Abnormality of the calf musculature (HP:0001430) | 2.16871384 |
| 84 | Action tremor (HP:0002345) | 2.16113322 |
| 85 | Decreased motor nerve conduction velocity (HP:0003431) | 2.15568612 |
| 86 | Nonprogressive disorder (HP:0003680) | 2.14625240 |
| 87 | Hypopigmentation of the fundus (HP:0007894) | 2.14244179 |
| 88 | Patchy hypopigmentation of hair (HP:0011365) | 2.13593983 |
| 89 | Hammertoe (HP:0001765) | 2.13237105 |
| 90 | Asymmetric septal hypertrophy (HP:0001670) | 2.13156565 |
| 91 | Thickened helices (HP:0000391) | 2.11044772 |
| 92 | Lower limb muscle weakness (HP:0007340) | 2.10908314 |
| 93 | Bulbar palsy (HP:0001283) | 2.10786528 |
| 94 | Coronal craniosynostosis (HP:0004440) | 2.10781774 |
| 95 | Hyporeflexia of lower limbs (HP:0002600) | 2.09943732 |
| 96 | Infantile muscular hypotonia (HP:0008947) | 2.09575577 |
| 97 | Hypokalemic alkalosis (HP:0001949) | 2.08814768 |
| 98 | Abnormality of the septum pellucidum (HP:0007375) | 2.07456156 |
| 99 | Abnormality of the salivary glands (HP:0010286) | 2.06982851 |
| 100 | Buphthalmos (HP:0000557) | 2.06914231 |
| 101 | Turricephaly (HP:0000262) | 2.06334432 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 2.06161661 |
| 103 | White forelock (HP:0002211) | 2.05634978 |
| 104 | Increased CSF protein (HP:0002922) | 2.05287449 |
| 105 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.02768760 |
| 106 | Aplasia of the phalanges of the hand (HP:0009802) | 2.02768760 |
| 107 | Aplasia involving bones of the extremities (HP:0009825) | 2.02768760 |
| 108 | Diaphragmatic weakness (HP:0009113) | 2.02132995 |
| 109 | Fetal akinesia sequence (HP:0001989) | 2.02034764 |
| 110 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.00921617 |
| 111 | Peripheral demyelination (HP:0011096) | 2.00757324 |
| 112 | Abnormal atrioventricular conduction (HP:0005150) | 2.00571756 |
| 113 | Neuroendocrine neoplasm (HP:0100634) | 1.99748579 |
| 114 | Acute necrotizing encephalopathy (HP:0006965) | 1.99124332 |
| 115 | Abnormality of the musculature of the hand (HP:0001421) | 1.98711707 |
| 116 | Split foot (HP:0001839) | 1.98402376 |
| 117 | Distal lower limb amyotrophy (HP:0008944) | 1.96416587 |
| 118 | Sudden death (HP:0001699) | 1.96171360 |
| 119 | Hypomagnesemia (HP:0002917) | 1.96061210 |
| 120 | Decreased lacrimation (HP:0000633) | 1.95576541 |
| 121 | Lower limb amyotrophy (HP:0007210) | 1.95369717 |
| 122 | Gowers sign (HP:0003391) | 1.95171730 |
| 123 | Exercise-induced myalgia (HP:0003738) | 1.94336375 |
| 124 | Vertebral compression fractures (HP:0002953) | 1.94076537 |
| 125 | Premature skin wrinkling (HP:0100678) | 1.92535026 |
| 126 | Difficulty running (HP:0009046) | 1.91848800 |
| 127 | Sleep apnea (HP:0010535) | 1.91291723 |
| 128 | Megalencephaly (HP:0001355) | 1.90610805 |
| 129 | Epiphyseal dysplasia (HP:0002656) | 1.88714047 |
| 130 | Focal seizures (HP:0007359) | 1.87613832 |
| 131 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.87291612 |
| 132 | Esophageal atresia (HP:0002032) | 1.86646282 |
| 133 | Achilles tendon contracture (HP:0001771) | 1.86554440 |
| 134 | Glomerulonephritis (HP:0000099) | 1.86431991 |
| 135 | Type II lissencephaly (HP:0007260) | 1.84822058 |
| 136 | Myelomeningocele (HP:0002475) | 1.84627723 |
| 137 | Craniofacial dystonia (HP:0012179) | 1.84127236 |
| 138 | Acute encephalopathy (HP:0006846) | 1.84064178 |
| 139 | Urinary urgency (HP:0000012) | 1.83555386 |
| 140 | Scapular winging (HP:0003691) | 1.82733565 |
| 141 | Heart block (HP:0012722) | 1.82720324 |
| 142 | Hemiparesis (HP:0001269) | 1.81215297 |
| 143 | Paraparesis (HP:0002385) | 1.80832407 |
| 144 | Prolonged neonatal jaundice (HP:0006579) | 1.80183443 |
| 145 | Distal sensory impairment (HP:0002936) | 1.80052070 |
| 146 | Confusion (HP:0001289) | 1.78941506 |
| 147 | Neuronal loss in central nervous system (HP:0002529) | 1.78649924 |
| 148 | Choreoathetosis (HP:0001266) | 1.78515008 |
| 149 | Spinal cord compression (HP:0002176) | 1.78261816 |
| 150 | Clonus (HP:0002169) | 1.78068354 |
| 151 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77405075 |
| 152 | Aplasia of the musculature (HP:0100854) | 1.77058909 |
| 153 | Ulnar claw (HP:0001178) | 1.76871941 |
| 154 | Focal dystonia (HP:0004373) | 1.76792973 |
| 155 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.76689415 |
| 156 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.76348912 |
| 157 | Generalized amyotrophy (HP:0003700) | 1.75247387 |
| 158 | Poor speech (HP:0002465) | 1.72585209 |
| 159 | Bowel incontinence (HP:0002607) | 1.72374377 |
| 160 | Urinary incontinence (HP:0000020) | 1.71749051 |
| 161 | Truncal ataxia (HP:0002078) | 1.70141586 |
| 162 | Neck muscle weakness (HP:0000467) | 1.69714223 |
| 163 | Complement deficiency (HP:0004431) | 1.68700557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.04966127 |
| 2 | EPHB1 | 4.26478216 |
| 3 | MAPKAPK5 | 4.08462503 |
| 4 | OXSR1 | 3.70375610 |
| 5 | PBK | 3.20278047 |
| 6 | RIPK1 | 3.07332109 |
| 7 | PKN1 | 2.93620731 |
| 8 | LMTK2 | 2.73327490 |
| 9 | PNCK | 2.69011077 |
| 10 | WNK4 | 2.52661396 |
| 11 | TESK2 | 2.41107150 |
| 12 | NTRK3 | 2.39681198 |
| 13 | BCR | 2.12425359 |
| 14 | UHMK1 | 2.09998448 |
| 15 | MET | 2.04985069 |
| 16 | DAPK2 | 2.04948985 |
| 17 | FGFR2 | 2.03293333 |
| 18 | LATS2 | 2.00294470 |
| 19 | LIMK1 | 1.94579789 |
| 20 | TRIB3 | 1.88532997 |
| 21 | WNK1 | 1.81626809 |
| 22 | MST4 | 1.70326410 |
| 23 | CAMK2B | 1.60280266 |
| 24 | MYLK | 1.59525123 |
| 25 | CSNK1G3 | 1.57278895 |
| 26 | NTRK1 | 1.56873971 |
| 27 | PDGFRA | 1.56112601 |
| 28 | CSNK1A1L | 1.54852925 |
| 29 | SGK494 | 1.50473479 |
| 30 | SGK223 | 1.50473479 |
| 31 | TTN | 1.47661649 |
| 32 | CLK1 | 1.42718874 |
| 33 | ROCK2 | 1.38279207 |
| 34 | CAMKK1 | 1.36807860 |
| 35 | MOS | 1.35965379 |
| 36 | CAMK2D | 1.29808230 |
| 37 | DYRK2 | 1.29353657 |
| 38 | CAMK1G | 1.23521285 |
| 39 | CDK19 | 1.23432415 |
| 40 | FGR | 1.21911402 |
| 41 | TESK1 | 1.19826221 |
| 42 | CSNK1G1 | 1.19019615 |
| 43 | MARK2 | 1.15130186 |
| 44 | MAP3K3 | 1.14951469 |
| 45 | CSNK1G2 | 1.13692587 |
| 46 | ERBB4 | 1.13532949 |
| 47 | CASK | 1.13120750 |
| 48 | MAP3K6 | 1.07938491 |
| 49 | RIPK4 | 1.05396645 |
| 50 | MAPKAPK3 | 1.04824243 |
| 51 | PRKD1 | 1.01854290 |
| 52 | MAPK15 | 1.00923830 |
| 53 | NEK6 | 0.98881078 |
| 54 | CAMK2G | 0.97400777 |
| 55 | MARK1 | 0.97292932 |
| 56 | FER | 0.97227838 |
| 57 | MUSK | 0.96720833 |
| 58 | RET | 0.96061879 |
| 59 | PTK2 | 0.95907549 |
| 60 | PDGFRB | 0.95364689 |
| 61 | MKNK1 | 0.94550825 |
| 62 | PINK1 | 0.94549208 |
| 63 | ERN1 | 0.93739922 |
| 64 | TNK2 | 0.90835691 |
| 65 | SIK1 | 0.90591791 |
| 66 | MAP2K2 | 0.90315764 |
| 67 | CAMK2A | 0.89892666 |
| 68 | NME2 | 0.89306728 |
| 69 | TIE1 | 0.88731705 |
| 70 | RPS6KA5 | 0.85530767 |
| 71 | MAP3K13 | 0.85266238 |
| 72 | SGK2 | 0.84862055 |
| 73 | TGFBR2 | 0.84386650 |
| 74 | PAK6 | 0.84125312 |
| 75 | PAK3 | 0.82722587 |
| 76 | PHKG2 | 0.81323058 |
| 77 | PHKG1 | 0.81323058 |
| 78 | EPHA3 | 0.80480832 |
| 79 | PRKCE | 0.77503904 |
| 80 | ICK | 0.77236643 |
| 81 | SGK3 | 0.75061754 |
| 82 | STK38 | 0.74237268 |
| 83 | ROCK1 | 0.73486685 |
| 84 | CDK14 | 0.73354871 |
| 85 | MINK1 | 0.71653508 |
| 86 | BMPR1B | 0.71457537 |
| 87 | PRKCQ | 0.70378083 |
| 88 | CDK5 | 0.69059147 |
| 89 | PAK4 | 0.66840364 |
| 90 | GSK3A | 0.65869367 |
| 91 | CDK15 | 0.65089552 |
| 92 | AKT3 | 0.64051582 |
| 93 | MAPK10 | 0.64017026 |
| 94 | MAP3K11 | 0.63446355 |
| 95 | SGK1 | 0.63036576 |
| 96 | MAP3K1 | 0.61810540 |
| 97 | CDC42BPA | 0.60517120 |
| 98 | TYRO3 | 0.59541157 |
| 99 | CDK18 | 0.59167632 |
| 100 | MAP2K1 | 0.57918073 |
| 101 | TNIK | 0.57493402 |
| 102 | CDK11A | 0.57250068 |
| 103 | PDK1 | 0.56325646 |
| 104 | PRKG1 | 0.56158444 |
| 105 | CSNK1D | 0.55612274 |
| 106 | GRK7 | 0.55224906 |
| 107 | DAPK1 | 0.53646182 |
| 108 | PDPK1 | 0.53133985 |
| 109 | KSR2 | 0.53040076 |
| 110 | ABL2 | 0.52120564 |
| 111 | EPHA4 | 0.51205895 |
| 112 | CAMK4 | 0.51140360 |
| 113 | PRKACB | 0.50183507 |
| 114 | CSNK1A1 | 0.47342433 |
| 115 | FYN | 0.46877230 |
| 116 | OBSCN | 0.46120189 |
| 117 | DDR2 | 0.45814512 |
| 118 | DAPK3 | 0.45534829 |
| 119 | MAPK13 | 0.44951686 |
| 120 | GRK5 | 0.44389650 |
| 121 | HIPK2 | 0.42214764 |
| 122 | ADRBK2 | 0.42127722 |
| 123 | BUB1 | 0.40956268 |
| 124 | NTRK2 | 0.39372595 |
| 125 | MAPK12 | 0.38213218 |
| 126 | PRKD3 | 0.38179883 |
| 127 | DMPK | 0.37917727 |
| 128 | MAP3K2 | 0.37142768 |
| 129 | PIK3CA | 0.37133764 |
| 130 | PRKACA | 0.35117926 |
| 131 | PAK1 | 0.34638965 |
| 132 | PAK2 | 0.34185974 |
| 133 | DYRK1A | 0.33561398 |
| 134 | PLK2 | 0.32062243 |
| 135 | ARAF | 0.31016090 |
| 136 | CSNK1E | 0.29643112 |
| 137 | PRPF4B | 0.29542549 |
| 138 | IRAK2 | 0.29399264 |
| 139 | GRK1 | 0.29362795 |
| 140 | MAPK4 | 0.29312526 |
| 141 | PRKD2 | 0.28831689 |
| 142 | PRKCH | 0.27922297 |
| 143 | INSR | 0.27732571 |
| 144 | CAMK1 | 0.26294363 |
| 145 | BMPR2 | 0.24840165 |
| 146 | STK11 | 0.24733325 |
| 147 | PTK2B | 0.24469840 |
| 148 | MAPK7 | 0.23754939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.73934119 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.87950099 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.85288716 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.37318385 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.19745832 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.05878408 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.80510551 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.67391664 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.24412017 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.20943281 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.12873610 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.04947856 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.99616943 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.90948574 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.88170618 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85325212 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.84307864 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.80634833 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77887670 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.73752387 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.68775018 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.63468830 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.52802545 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.52386545 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.48741656 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47693921 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47074524 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.46670402 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.46580721 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.46319345 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44179855 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43474162 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36143704 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.31541136 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.27635456 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.24753641 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17553834 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17282286 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13641157 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.13162547 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11680182 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.11625585 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.10192207 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.08847061 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08321746 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08238255 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08238105 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07209697 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05791829 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05533526 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05392139 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 1.03117132 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.02937478 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01700931 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99119387 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92073319 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.90769878 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85955836 |
| 59 | Long-term depression_Homo sapiens_hsa04730 | 0.84870479 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84826976 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83362451 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82857778 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82121381 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.81616522 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81322695 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80417137 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.79697990 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79643047 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.79113313 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78811286 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77042049 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75316417 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74957240 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74612223 |
| 75 | Tight junction_Homo sapiens_hsa04530 | 0.74064990 |
| 76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71714024 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71673884 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69579318 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69544485 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68269596 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67919647 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67910944 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67322096 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66522744 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66438432 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65874341 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65591268 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.65328292 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64622411 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63435004 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63424310 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62862969 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.61027273 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60774935 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60370909 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58397148 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57756192 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57182161 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56851150 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.56378739 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55298201 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52538015 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52382545 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51827100 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51474199 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51326694 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50001026 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49949550 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49245892 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48867700 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48475443 |
| 112 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48071411 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47011878 |
| 114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46335745 |
| 115 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46277688 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45957381 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.45747579 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45730243 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.45622858 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45438338 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45415079 |
| 122 | Phototransduction_Homo sapiens_hsa04744 | 0.45157216 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45131135 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.44726486 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44598765 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43189474 |
| 127 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43022985 |
| 128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42630266 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42614138 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39124372 |
| 131 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39039419 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39004920 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38555520 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38100473 |
| 135 | Renin secretion_Homo sapiens_hsa04924 | 0.37854064 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.37846383 |
| 137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36430416 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.36060774 |
| 139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34284437 |
| 140 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34143022 |
| 141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32855157 |
| 142 | Gap junction_Homo sapiens_hsa04540 | 0.31735591 |
| 143 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31017626 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.28141543 |
| 145 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27664672 |
| 146 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.26955658 |
| 147 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25981769 |
| 148 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23874291 |
| 149 | Taste transduction_Homo sapiens_hsa04742 | 0.23458606 |
| 150 | Nicotine addiction_Homo sapiens_hsa05033 | 0.21244086 |
| 151 | Melanogenesis_Homo sapiens_hsa04916 | 0.20740702 |
| 152 | ABC transporters_Homo sapiens_hsa02010 | 0.19806671 |

